News Select Year All Years 2026 (21) 2025 (37) 2024 (31) 2023 (31) 2022 (35) 2021 (28) 2020 (36) 2019 (46) 2018 (51) 2017 (34) 2016 (26) 2015 (42) 2014 (30) 2013 (26) 2012 (23) 2011 (28) 2010 (36) 2009 (39) 2008 (55) 2007 (50) Clinical Trials Select Clinical Trial AWARE-1 (21) BRACELET-1 (10) GOBLET (35) Search … June 29, 2016 Oncolytics Biotech® Inc. Announces Phase 2 Study in Female Patients with Colorectal Cancer Metastatic to the Liver May 19, 2016 Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Non-Small Cell Lung Cancer May 19, 2016 Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Colorectal Cancer May 6, 2016 Oncolytics Biotech® Inc. Announces 2016 First Quarter Results May 6, 2016 Oncolytics Biotech® Inc. Announces Voting Results from its Annual Meeting of Shareholders May 5, 2016 Oncolytics Biotech® Inc. Announces Presentation of REOLYSIN® Preclinical Research at the 2016 ASGCT Annual Meeting May 3, 2016 Oncolytics Biotech® Inc. Announces Details of 2016 Annual Meeting of Shareholders April 29, 2016 Oncolytics Biotech® Inc. Announces Formation of Science and Technology Committee April 29, 2016 Oncolytics Biotech® Inc. to Participate in the Bloom Burton & Co. Healthcare Investor Conference April 18, 2016 Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Research at the 2016 AACR Annual Meeting Newer Page 37 of 71 Older